Skip to main content
Explore URMC

UCCS20154 / APATIT-G / Akwaa

Research Question:
cancer study doesn't need posting

Basic Study Information

The purpose of this study is to determine if using avatrombopag in patients with thrombocytopenia due to temozolomide treatment can safely improve a patient's platelet count and allow the patient to complete the temozolomide treatment course as planned.

Location: University of Rochester Medical Center

Lead Researcher (Principal Investigator)

Lead Researcher:  Frank Akwaa

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search